{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:10:17Z","timestamp":1781280617845,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["4800-4845-300"],"award-info":[{"award-number":["4800-4845-300"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["4800-4859-300"],"award-info":[{"award-number":["4800-4859-300"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2012-NG48002-00"],"award-info":[{"award-number":["2012-NG48002-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2020-NI-017-00"],"award-info":[{"award-number":["2020-NI-017-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2021.06.060","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T23:50:47Z","timestamp":1627602647000},"page":"5214-5223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of an attenuated smallpox vaccine candidate: The KVAC103 strain"],"prefix":"10.1016","volume":"39","author":[{"given":"Heeji","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ju","family":"In","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Ha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sik","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyung Tae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gu","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.vaccine.2021.06.060_b0005","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1056\/NEJMra020025","article-title":"Diagnosis and Management of Smallpox","volume":"346","author":"Breman","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.060_b0010","doi-asserted-by":"crossref","unstructured":"Elwood JM. Smallpox and its eradication. J Epidemiol Commun Health 1989;43(1):92\u201392.","DOI":"10.1136\/jech.43.1.92"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.060_b0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6510a2","article-title":"Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015","volume":"65","author":"Petersen","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.060_b0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3855\/jidc.258","article-title":"When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond","volume":"2","author":"Moussatche","year":"2008","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.060_b0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00705-009-0562-y","article-title":"Partial genetic characterization of viruses isolated from pox-like infection in cattle and buffaloes: evidence of buffalo pox virus circulation in Indian cows","volume":"155","author":"Yadav","year":"2010","journal-title":"Arch Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.060_b0030","first-page":"E070419.3","article-title":"Sporadic human cases of cowpox in Germany","volume":"12","author":"Nitsche","year":"2007","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.060_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","article-title":"Zoonotic poxvirus infections in humans","volume":"17","author":"Lewis-Jones","year":"2004","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.060_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","article-title":"Human monkeypox: an emerging zoonosis","volume":"4","author":"Di Giulio","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.060_b0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans","volume":"6","author":"Sklenovska","year":"2018","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.060_b0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.060_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2017.08.003","article-title":"Cowpox Virus: A New and Armed Oncolytic Poxvirus","volume":"7","author":"Ricordel","year":"2017","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.060_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13337-012-0068-1","article-title":"Emergence and reemergence of vaccinia-like viruses: global scenario and perspectives","volume":"23","author":"Singh","year":"2012","journal-title":"Indian J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2021.06.060_b0065","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.060_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.060_b0075","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/14760584.7.8.1225","article-title":"Smallpox vaccines for biodefense: need and feasibility","volume":"7","author":"Artenstein","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.060_b0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: a review of preclinical and clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2021.06.060_b0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des Devel Ther"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2021.06.060_b0090","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B"},{"issue":"6979","key":"10.1016\/j.vaccine.2021.06.060_b0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.060_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149364","article-title":"Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines","volume":"11","author":"Meseda","year":"2016","journal-title":"PLoS ONE"},{"issue":"45","key":"10.1016\/j.vaccine.2021.06.060_b0105","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.vaccine.2015.07.111","article-title":"Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8","volume":"33","author":"Eto","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.060_b0110","first-page":"88","article-title":"Properties of Attenuated Mutant of Vaccinia Virus, LC16m8, Derived from Lister Strain","author":"Hashizume","year":"1985","journal-title":"Vaccinia Viruses as Vectors for Vaccine Antigens"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.060_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.060_b0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2009.04.004","article-title":"The immunology of smallpox vaccines","volume":"21","author":"Kennedy","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"47","key":"10.1016\/j.vaccine.2021.06.060_b0125","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: An attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.060_b0130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/14760584.2016.1175305","article-title":"Defending against smallpox: a focus on vaccines AU - Voigt, Emily A","volume":"15","author":"Kennedy","year":"2016","journal-title":"Exp Rev Vacc"},{"issue":"Pt A","key":"10.1016\/j.vaccine.2021.06.060_b0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0076-6879(81)78139-4","article-title":"Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays","volume":"78","author":"Langford","year":"1981","journal-title":"Meth Enzymol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.060_b0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nmeth.2474","article-title":"Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data","volume":"10","author":"Chin","year":"2013","journal-title":"Nat Meth"},{"key":"10.1016\/j.vaccine.2021.06.060_b0145","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btx373","article-title":"FQC Dashboard: integrates FastQC results into a web-based, interactive, and extensible FASTQ quality control tool","author":"Brown","year":"2017","journal-title":"Bioinformatics"},{"issue":"15","key":"10.1016\/j.vaccine.2021.06.060_b0150","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.060_b0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: the European Molecular Biology Open Software Suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.060_b0160","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1099\/ijsem.0.000760","article-title":"OrthoANI: An improved algorithm and software for calculating average nucleotide identity","volume":"66","author":"Lee","year":"2016","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.vaccine.2021.06.060_b0165","unstructured":"WHO. Smallpox, bioterrorism and World Health Organization; 2006."},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.060_b0170","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1473-3099(05)70242-5","article-title":"Smallpox vaccine and its stockpile in 2005","volume":"5","author":"Arita","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.060_b0175","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2021.06.060_b0180","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.vaccine.2003.10.022","article-title":"Mouse neurotoxicity test for vaccinia-based smallpox vaccines","volume":"22","author":"Li","year":"2004","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2021.06.060_b0185","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1016\/j.vaccine.2007.09.023","article-title":"Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice","volume":"25","author":"Melamed","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.060_b0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/icb.2009.110","article-title":"Antiviral protection following immunization correlates with humoral but not cell-mediated immunity","volume":"88","author":"Panchanathan","year":"2010","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.060_b0195","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"Gordon","year":"2011","journal-title":"J Infect Dis"},{"issue":"49","key":"10.1016\/j.vaccine.2021.06.060_b0200","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1016\/j.vaccine.2007.09.050","article-title":"Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate","volume":"25","author":"Ferrier-Rembert","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.060_b0205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms","volume":"29","author":"Perdiguero","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"19","key":"10.1016\/j.vaccine.2021.06.060_b0210","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1073\/pnas.1215995110","article-title":"Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation","volume":"110","author":"Gerlic","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.060_b0215","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1074\/jbc.M109.078113","article-title":"Vaccinia virus protein F1L is a caspase-9 inhibitor","volume":"285","author":"Zhai","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.060_b0220","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0042-6822(91)90158-8","article-title":"Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon","volume":"183","author":"Beattie","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.060_b0225","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/JVI.00254-10","article-title":"Roles of vaccinia virus genes E3L and K3L and host genes PKR and RNase L during intratracheal infection of C57BL\/6 mice","volume":"85","author":"Rice","year":"2011","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2021.06.060_b0230","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00542-17","article-title":"Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity","volume":"91","author":"Bravo Cruz","year":"2017","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:16:31Z","timestamp":1777536991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21008100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":46,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X21008100"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an attenuated smallpox vaccine candidate: The KVAC103 strain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}